Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization

References

• Mestecky J, Michalek SM, Moldoveanu Z, Russell MW. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Behring Inst Mitt 1997; 33 - 43; PMID: 9382757
   PubMedGoogle Scholar
• Jakobsen H, Jonsdottir I. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?. Scand J Immunol 2003; 58:119 - 28; http://dx.doi.org/10.1046/j.1365-3083.2003.01292.x; PMID: 12869132
   PubMed Web of Science ®Google Scholar
• Haase AT. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464:217 - 23; http://dx.doi.org/10.1038/nature08757; PMID: 20220840
   PubMed Web of Science ®Google Scholar
• Virgin HW, Walker BD. Immunology and the elusive AIDS vaccine. Nature 2010; 464:224 - 31; http://dx.doi.org/10.1038/nature08898; PMID: 20220841
   PubMed Web of Science ®Google Scholar
• Lamm ME. Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 1997; 51:311 - 40; http://dx.doi.org/10.1146/annurev.micro.51.1.311; PMID: 9343353
   PubMed Web of Science ®Google Scholar
• Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME. A three-tiered view of the role of IgA in mucosal defense. Immunol Today 1993; 14:430 - 5; http://dx.doi.org/10.1016/0167-5699(93)90245-G; PMID: 8216720
   PubMedGoogle Scholar
• Bomsel M, Tudor D, Drillet AS, Alfsen A, Ganor Y, Roger MG, et al. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 2011; 34:269 - 80; http://dx.doi.org/10.1016/j.immuni.2011.01.015; PMID: 21315623
   PubMed Web of Science ®Google Scholar
• Bonenfant C, Dimier-Poisson I, Velge-Roussel F, Buzoni-Gatel D, Del Giudice G, Rappuoli R, et al. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun 2001; 69:1605 - 12; http://dx.doi.org/10.1128/IAI.69.3.1605-1612.2001; PMID: 11179334
   PubMed Web of Science ®Google Scholar
• Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, et al. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 2002; 169:566 - 74; PMID: 12077289
   PubMed Web of Science ®Google Scholar
• Mestecky J, Fultz PN. Mucosal immune system of the human genital tract. J Infect Dis 1999; 179:Suppl 3 S470 - 4; http://dx.doi.org/10.1086/314806; PMID: 10099122
   PubMed Web of Science ®Google Scholar
• Chen W, Patel GB, Yan H, Zhang J. Recent advances in the development of novel mucosal adjuvants and antigen delivery systems. Hum Vaccin 2010; 6:6; http://dx.doi.org/10.4161/hv.6.9.11561; PMID: 20861683
   PubMed Web of Science ®Google Scholar
• Ramos HC, Rumbo M, Sirard JC. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol 2004; 12:509 - 17; http://dx.doi.org/10.1016/j.tim.2004.09.002; PMID: 15488392
   PubMed Web of Science ®Google Scholar
• Homma M, Fujita H, Yamaguchi S, Iino T. Regions of Salmonella typhimurium flagellin essential for its polymerization and excretion. J Bacteriol 1987; 169:291 - 6; PMID: 3539920
   PubMed Web of Science ®Google Scholar
• Eaves-Pyles TD, Wong HR, Odoms K, Pyles RB. Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein. J Immunol 2001; 167:7009 - 16; PMID: 11739521
   PubMed Web of Science ®Google Scholar
• Murthy KG, Deb A, Goonesekera S, Szabó C, Salzman AL. Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro. J Biol Chem 2004; 279:5667 - 75; http://dx.doi.org/10.1074/jbc.M307759200; PMID: 14634022
   PubMed Web of Science ®Google Scholar
• McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, et al. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis 2007; 195:1607 - 17; http://dx.doi.org/10.1086/517613; PMID: 17471430
   PubMed Web of Science ®Google Scholar
• Mizel SB, Bates JT. Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol 2010; 185:5677 - 82; http://dx.doi.org/10.4049/jimmunol.1002156; PMID: 21048152
   PubMed Web of Science ®Google Scholar
• Honko AN, Sriranganathan N, Lees CJ, Mizel SB. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun 2006; 74:1113 - 20; http://dx.doi.org/10.1128/IAI.74.2.1113-1120.2006; PMID: 16428759
   PubMed Web of Science ®Google Scholar
• Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, et al. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 2007; 25:763 - 75; http://dx.doi.org/10.1016/j.vaccine.2006.08.013; PMID: 16968658
   PubMed Web of Science ®Google Scholar
• Adar Y, Singer Y, Levi R, Tzehoval E, Perk S, Banet-Noach C, et al. A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine 2009; 27:2099 - 107; http://dx.doi.org/10.1016/j.vaccine.2009.02.011; PMID: 19356612
   PubMed Web of Science ®Google Scholar
• Bargieri DY, Leite JA, Lopes SC, Sbrogio-Almeida ME, Braga CJ, Ferreira LC, et al. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium. Vaccine 2010; 28:2818 - 26; http://dx.doi.org/10.1016/j.vaccine.2010.02.004; PMID: 20170765
   PubMed Web of Science ®Google Scholar
• Song L, Zhang Y, Yun NE, Poussard AL, Smith JN, Smith JK, et al. Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin. Vaccine 2009; 27:5875 - 84; http://dx.doi.org/10.1016/j.vaccine.2009.07.060; PMID: 19654064
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, et al. Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine 2010; 28:8268 - 74; http://dx.doi.org/10.1016/j.vaccine.2010.10.009; PMID: 20969925
   PubMed Web of Science ®Google Scholar
• Taylor DN, Treanor JJ, Strout C, Johnson C, Fitzgerald T, Kavita U, et al. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI). Vaccine 2011; 29:4897 - 902; http://dx.doi.org/10.1016/j.vaccine.2011.05.001; PMID: 21596084
   PubMed Web of Science ®Google Scholar
• Bargieri DY, Soares IS, Costa FT, Braga CJ, Ferreira LC, Rodrigues MM. . Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?J Parasitol Res2011; 2011:965369.
   PubMedGoogle Scholar
• Sun Y, Shi W, Yang JY, Zhou DH, Chen YQ, Zhang Y, et al. Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine. J Dent Res 2012; 91:941 - 7; http://dx.doi.org/10.1177/0022034512457684; PMID: 22895510
   PubMed Web of Science ®Google Scholar
• Nempont C, Cayet D, Rumbo M, Bompard C, Villeret V, Sirard JC. Deletion of flagellin’s hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity. J Immunol 2008; 181:2036 - 43; PMID: 18641341
   PubMed Web of Science ®Google Scholar
• Taylor DN, Treanor JJ, Sheldon EA, Johnson C, Umlauf S, Song L, et al. Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response. Vaccine 2012; 30:5761 - 9; http://dx.doi.org/10.1016/j.vaccine.2012.06.086; PMID: 22796139
   PubMed Web of Science ®Google Scholar
• Turley CB, Rupp RE, Johnson C, Taylor DN, Wolfson J, Tussey L, et al. Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine 2011; 29:5145 - 52; http://dx.doi.org/10.1016/j.vaccine.2011.05.041; PMID: 21624416
   PubMed Web of Science ®Google Scholar
• Liu F, Yang J, Zhang Y, Zhou D, Chen Y, Gai W, et al. Recombinant flagellins with partial deletions of the hypervariable domain lose antigenicity but not mucosal adjuvancy. Biochem Biophys Res Commun 2010; 392:582 - 7; http://dx.doi.org/10.1016/j.bbrc.2010.01.077; PMID: 20102702
   PubMed Web of Science ®Google Scholar
• Sanders CJ, Franchi L, Yarovinsky F, Uematsu S, Akira S, Núñez G, et al. Induction of adaptive immunity by flagellin does not require robust activation of innate immunity. Eur J Immunol 2009; 39:359 - 71; http://dx.doi.org/10.1002/eji.200838804; PMID: 19152336
   PubMed Web of Science ®Google Scholar
• Barton BE. IL-6: insights into novel biological activities. Clin Immunol Immunopathol 1997; 85:16 - 20; http://dx.doi.org/10.1006/clin.1997.4420; PMID: 9325064
   PubMedGoogle Scholar
• Schumacher C, Clark-Lewis I, Baggiolini M, Moser B. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci U S A 1992; 89:10542 - 6; http://dx.doi.org/10.1073/pnas.89.21.10542; PMID: 1438244
   PubMed Web of Science ®Google Scholar
• Liaudet L, Murthy KG, Mabley JG, Pacher P, Soriano FG, Salzman AL, et al. Comparison of inflammation, organ damage, and oxidant stress induced by Salmonella enterica serovar Muenchen flagellin and serovar Enteritidis lipopolysaccharide. Infect Immun 2002; 70:192 - 8; http://dx.doi.org/10.1128/IAI.70.1.192-198.2002; PMID: 11748182
   PubMed Web of Science ®Google Scholar
• Vassilieva EV, Wang BZ, Vzorov AN, Wang L, Wang YC, Bozja J, et al. Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant. MBio 2011; 2:e00328 - 10; http://dx.doi.org/10.1128/mBio.00328-10; PMID: 21325038
   PubMed Web of Science ®Google Scholar
• Lycke NY. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation. J Immunol 1993; 150:4810 - 21; PMID: 8388421
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 2009; 70:505 - 15; http://dx.doi.org/10.1111/j.1365-3083.2009.02319.x; PMID: 19906191
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007; 25:5467 - 84; http://dx.doi.org/10.1016/j.vaccine.2006.12.001; PMID: 17227687
   PubMed Web of Science ®Google Scholar
• Chorny A, Puga I, Cerutti A. Innate signaling networks in mucosal IgA class switching. Adv Immunol 2010; 107:31 - 69; http://dx.doi.org/10.1016/B978-0-12-381300-8.00002-2; PMID: 21034970
   PubMed Web of Science ®Google Scholar
• Monteiro RC. Role of IgA and IgA fc receptors in inflammation. J Clin Immunol 2010; 30:1 - 9; http://dx.doi.org/10.1007/s10875-009-9338-0; PMID: 19834792
   PubMed Web of Science ®Google Scholar
• Ben Mkaddem S, Rossato E, Heming N, Monteiro RC. Anti-inflammatory role of the IgA Fc receptor (CD89): From autoimmunity to therapeutic perspectives. Autoimmun Rev 2012; In Press http://dx.doi.org/10.1016/j.autrev.2012.10.011; PMID: 23201915
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yang J, Shi J, Gong Y-N, Lu Q, Xu H, et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 2011; 477:596 - 600; http://dx.doi.org/10.1038/nature10510; PMID: 21918512
   PubMed Web of Science ®Google Scholar
• Miao EA, Andersen-Nissen E, Warren SE, Aderem A. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin Immunopathol 2007; 29:275 - 88; http://dx.doi.org/10.1007/s00281-007-0078-z; PMID: 17690885
   PubMed Web of Science ®Google Scholar
• Honko AN, Mizel SB. Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect Immun 2004; 72:6676 - 9; http://dx.doi.org/10.1128/IAI.72.11.6676-6679.2004; PMID: 15501801
   PubMed Web of Science ®Google Scholar
• Aida Y, Pabst MJ. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods 1990; 132:191 - 5; http://dx.doi.org/10.1016/0022-1759(90)90029-U; PMID: 2170533
   PubMed Web of Science ®Google Scholar
• Liu S, Tobias R, McClure S, Styba G, Shi Q, Jackowski G. Removal of endotoxin from recombinant protein preparations. Clin Biochem 1997; 30:455 - 63; http://dx.doi.org/10.1016/S0009-9120(97)00049-0; PMID: 9316739
   PubMed Web of Science ®Google Scholar
• McCoy SL, Kurtz SE, Hausman FA, Trune DR, Bennett RM, Hefeneider SH. Activation of RAW264.7 macrophages by bacterial DNA and lipopolysaccharide increases cell surface DNA binding and internalization. J Biol Chem 2004; 279:17217 - 23; http://dx.doi.org/10.1074/jbc.M303837200; PMID: 14757773
   PubMed Web of Science ®Google Scholar
• West AP, Dancho BA, Mizel SB. Gangliosides inhibit flagellin signaling in the absence of an effect on flagellin binding to toll-like receptor 5. J Biol Chem 2005; 280:9482 - 8; http://dx.doi.org/10.1074/jbc.M411875200; PMID: 15632166
   PubMed Web of Science ®Google Scholar
• Gai W, Zou W, Lei L, Luo J, Tu H, Zhang Y, et al. Effects of different immunization protocols and adjuvant on antibody responses to inactivated SARS-CoV vaccine. Viral Immunol 2008; 21:27 - 37; http://dx.doi.org/10.1089/vim.2007.0079; PMID: 18355120
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang J, Bao R, Chen Y, Zhou D, He B, et al. Unpolarized release of vaccinia virus and HIV antigen by colchicine treatment enhances intranasal HIV antigen expression and mucosal humoral responses. PLoS One 2011; 6:e24296; http://dx.doi.org/10.1371/journal.pone.0024296; PMID: 21935396
   PubMed Web of Science ®Google Scholar
• Zhong M, He B, Yang J, Bao R, Zhang Y, Zhou D, et al. L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicide. Antimicrob Agents Chemother 2012; 56:3121 - 32; http://dx.doi.org/10.1128/AAC.05950-11; PMID: 22391529
   PubMed Web of Science ®Google Scholar
• Lambert C, Léonard N, De Bolle X, Depiereux E. ESyPred3D: Prediction of proteins 3D structures. Bioinformatics 2002; 18:1250 - 6; http://dx.doi.org/10.1093/bioinformatics/18.9.1250; PMID: 12217917
   PubMed Web of Science ®Google Scholar